Usefulness of platelet rich plasma in Androgenetic alopecia | [Pakistan Armed Forces Medical Journal • 2022]

Author(s):

1. Nadia Iftikhar: Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan,

2. Kanza Aftab: Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan,

3. Majid Hussain: Combined Military Hospital Abbottabad/National University of Medical Sciences (NUMS), Pakistan

4. Shanza Obaid: Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan

5. Zarnab Zainab: Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Rawalpindi,Pakistan

6. Maimoona Mushtaq: Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Rawalpindi,Pakistan

Abstract:

Objective: To study the usefulness of platelet-rich plasma in patients of androgenetic alopecia at the Dermatology Department of Pak Emirates Military Hospital Rawalpindi, Pakistan. Study Design: Case series. Place and Duration of Study: Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi Pakistan, from Dec 2018 to Jan 2020. Methodology: A total of 50 patients with androgenetic alopecia diagnosed by the consultant dermatologist were included in this study. Patients were administered platelet-rich plasma every four weeks for three sessions. Hair pull test and subjective improvement of patients (0-10) were used to see the treatment response. Results: Out of 50 patients with androgenetic alopecia, 36 (72%) had satisfactory responses while 14 (28%) had not achieved the satisfactory response after the twelve-weeks treatment comprising of three sessions. The absence of comorbid medical illness and less age of the patients had a statistically significant relationship with the presence of satisfactory response in the study population (p-value 0.010 and 0.001). Conclusion: A significant number of patients with androgenetic alopecia responded very well to platelet-rich plasma. Chances of achieving a satisfactory response increase if the patient is not having any comorbid medical illness and is less than the age of 40 years at the time of treatment.

Page(s): 112-114

DOI: 10.51253/pafmj.v72i1.4337

Published: Journal: Pakistan Armed Forces Medical Journal, Volume: 72, Issue: 1, Year: 2022

Keywords:

treatment response , Platelet rich plasma , androgenetic alopecia

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views